121 related articles for article (PubMed ID: 2454361)
1. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of carvedilol in exercise-induced myocardial ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
[TBL] [Abstract][Full Text] [Related]
3. Comparison of carvedilol and atenolol for angina pectoris.
Freedman SB; Jamal SM; Harris PJ; Kelly DT
Am J Cardiol; 1987 Sep; 60(7):499-502. PubMed ID: 2888302
[TBL] [Abstract][Full Text] [Related]
4. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease.
Lahiri A; Rodrigues EA; DasGupta P; Jain D; van der Does R; Raftery EB
Z Kardiol; 1989; 78 Suppl 3():21-7. PubMed ID: 2573213
[TBL] [Abstract][Full Text] [Related]
5. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
Rodrigues EA; Lahiri A; Hughes LO; Kohli RS; Whittington JR; Raftery EB
Am J Cardiol; 1986 Nov; 58(10):916-21. PubMed ID: 2877564
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
Am J Cardiol; 1985 Jul; 56(1):35-40. PubMed ID: 2861738
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol versus verapamil in chronic stable angina: a multicentre trial.
Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E
Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677
[TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F
Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939
[TBL] [Abstract][Full Text] [Related]
11. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
[TBL] [Abstract][Full Text] [Related]
12. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.
Nahrendorf W; Rading A; Steinig G; van der Does R; Schlote A
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S114-6. PubMed ID: 1378136
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
[TBL] [Abstract][Full Text] [Related]
14. Circadian antihypertensive profile of carvedilol (BM 14190).
Meyer-Sabellek W; Schulte KL; Distler A; Gotzen R
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S119-23. PubMed ID: 2454357
[TBL] [Abstract][Full Text] [Related]
15. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
Lahiri A; Rodrigues EA; Al-Khawaja I; Raftery EB
Am J Cardiol; 1987 Apr; 59(8):769-74. PubMed ID: 2881480
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kozyreva MP; Slastnikova ID; Vakulovskaia MK
Eksp Klin Farmakol; 1994; 57(3):47-50. PubMed ID: 7914121
[TBL] [Abstract][Full Text] [Related]
19. Multiple action compounds in angina pectoris.
Kelly DT; Freedman SB
Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
[TBL] [Abstract][Full Text] [Related]
20. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
